PG2 Injection for the Treatment of moderate-to Severe Fatigue in Breast Cancer Patients
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Cancer-related Fatigue
Interventions: DRUG: PG2 Lyo. Injection 500mg|DRUG: Placebo 0.9% normal saline
Sponsor: PhytoHealth Corporation